| Record Information |
|---|
| Version | 2.0 |
|---|
| Created at | 2022-09-06 13:43:52 UTC |
|---|
| Updated at | 2022-09-06 13:43:52 UTC |
|---|
| NP-MRD ID | NP0232476 |
|---|
| Secondary Accession Numbers | None |
|---|
| Natural Product Identification |
|---|
| Common Name | n-[(2s)-1-{[(2s,4e,7e)-1-(3-hexyl-4-oxooxetan-2-yl)trideca-4,7-dien-2-yl]oxy}-4-methyl-1-oxopentan-2-yl]carboximidic acid |
|---|
| Description | Lipstatin belongs to the class of organic compounds known as leucine and derivatives. Leucine and derivatives are compounds containing leucine or a derivative thereof resulting from reaction of leucine at the amino group or the carboxy group, or from the replacement of any hydrogen of glycine by a heteroatom. n-[(2s)-1-{[(2s,4e,7e)-1-(3-hexyl-4-oxooxetan-2-yl)trideca-4,7-dien-2-yl]oxy}-4-methyl-1-oxopentan-2-yl]carboximidic acid is found in Streptomyces toxytricini. n-[(2s)-1-{[(2s,4e,7e)-1-(3-hexyl-4-oxooxetan-2-yl)trideca-4,7-dien-2-yl]oxy}-4-methyl-1-oxopentan-2-yl]carboximidic acid was first documented in 2018 (PMID: 30020314). Based on a literature review a small amount of articles have been published on Lipstatin (PMID: 32181113) (PMID: 30763089) (PMID: 29291142) (PMID: 35810867). |
|---|
| Structure | CCCCCCC1C(C[C@H](C\C=C\C\C=C\CCCCC)OC(=O)[C@H](CC(C)C)N=CO)OC1=O InChI=1S/C29H49NO5/c1-5-7-9-11-12-13-14-15-16-18-24(34-29(33)26(30-22-31)20-23(3)4)21-27-25(28(32)35-27)19-17-10-8-6-2/h12-13,15-16,22-27H,5-11,14,17-21H2,1-4H3,(H,30,31)/b13-12+,16-15+/t24-,25?,26-,27?/m0/s1 |
|---|
| Synonyms | Not Available |
|---|
| Chemical Formula | C29H49NO5 |
|---|
| Average Mass | 491.7130 Da |
|---|
| Monoisotopic Mass | 491.36107 Da |
|---|
| IUPAC Name | N-[(2S)-1-{[(2S,4E,7E)-1-(3-hexyl-4-oxooxetan-2-yl)trideca-4,7-dien-2-yl]oxy}-4-methyl-1-oxopentan-2-yl]carboximidic acid |
|---|
| Traditional Name | N-[(2S)-1-{[(2S,4E,7E)-1-(3-hexyl-4-oxooxetan-2-yl)trideca-4,7-dien-2-yl]oxy}-4-methyl-1-oxopentan-2-yl]carboximidic acid |
|---|
| CAS Registry Number | Not Available |
|---|
| SMILES | CCCCCCC1C(C[C@H](C\C=C\C\C=C\CCCCC)OC(=O)[C@H](CC(C)C)N=CO)OC1=O |
|---|
| InChI Identifier | InChI=1S/C29H49NO5/c1-5-7-9-11-12-13-14-15-16-18-24(34-29(33)26(30-22-31)20-23(3)4)21-27-25(28(32)35-27)19-17-10-8-6-2/h12-13,15-16,22-27H,5-11,14,17-21H2,1-4H3,(H,30,31)/b13-12+,16-15+/t24-,25?,26-,27?/m0/s1 |
|---|
| InChI Key | OQMAKWGYQLJJIA-OWXRFHRVSA-N |
|---|
| Experimental Spectra |
|---|
|
| Not Available | | Predicted Spectra |
|---|
|
| | Spectrum Type | Description | Depositor ID | Depositor Organization | Depositor | Deposition Date | View |
|---|
| 1D NMR | 13C NMR Spectrum (1D, 25 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 100 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 252 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 1000 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 50 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 200 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 75 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 300 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 101 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 400 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 126 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 500 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 151 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 600 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 176 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 700 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 201 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 800 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 226 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 900 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum |
| | Chemical Shift Submissions |
|---|
|
| Not Available | | Species |
|---|
| Species of Origin | |
|---|
| Chemical Taxonomy |
|---|
| Description | Belongs to the class of organic compounds known as leucine and derivatives. Leucine and derivatives are compounds containing leucine or a derivative thereof resulting from reaction of leucine at the amino group or the carboxy group, or from the replacement of any hydrogen of glycine by a heteroatom. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Organic acids and derivatives |
|---|
| Class | Carboxylic acids and derivatives |
|---|
| Sub Class | Amino acids, peptides, and analogues |
|---|
| Direct Parent | Leucine and derivatives |
|---|
| Alternative Parents | |
|---|
| Substituents | - Leucine or derivatives
- Alpha-amino acid ester
- Fatty acid ester
- Fatty acyl
- Dicarboxylic acid or derivatives
- Beta_propiolactone
- Oxetane
- Lactone
- Carboxylic acid ester
- Oxacycle
- Organoheterocyclic compound
- Organic 1,3-dipolar compound
- Propargyl-type 1,3-dipolar organic compound
- Carboximidic acid derivative
- Carboximidic acid
- Organic nitrogen compound
- Organic oxygen compound
- Organopnictogen compound
- Organic oxide
- Hydrocarbon derivative
- Organooxygen compound
- Organonitrogen compound
- Carbonyl group
- Aliphatic heteromonocyclic compound
|
|---|
| Molecular Framework | Aliphatic heteromonocyclic compounds |
|---|
| External Descriptors | Not Available |
|---|
| Physical Properties |
|---|
| State | Not Available |
|---|
| Experimental Properties | | Property | Value | Reference |
|---|
| Melting Point | Not Available | Not Available | | Boiling Point | Not Available | Not Available | | Water Solubility | Not Available | Not Available | | LogP | Not Available | Not Available |
|
|---|
| Predicted Properties | |
|---|
| General References | - Khushboo, Pinki, Kumar P, Tripathi A, Luthra U, Dubey KK: Enhanced production of lipstatin from mutant of Streptomyces toxytricini and fed-batch strategies under submerged fermentation. 3 Biotech. 2020 Apr;10(4):151. doi: 10.1007/s13205-020-2147-0. Epub 2020 Mar 3. [PubMed:32181113 ]
- Zhang D, Zhang F, Liu W: A KAS-III Heterodimer in Lipstatin Biosynthesis Nondecarboxylatively Condenses C8 and C14 Fatty Acyl-CoA Substrates by a Variable Mechanism during the Establishment of a C22 Aliphatic Skeleton. J Am Chem Soc. 2019 Mar 6;141(9):3993-4001. doi: 10.1021/jacs.8b12843. Epub 2019 Feb 21. [PubMed:30763089 ]
- Menezes-Rodrigues FS, Errante PR, Ferreira RM, Tavares JGP, Paula L, Araujo EA, Govato TCP, Tikazawa EH, Reis MDCM, Luna-Filho B, Ferraz RRN, Oliveira-Junior IS, Taha MO, Caricati-Neto A: Cardioprotective effect of lipstatin derivative orlistat on normotensive rats submitted to cardiac ischemia and reperfusion. Acta Cir Bras. 2018 Jun;33(6):524-532. doi: 10.1590/s0102-865020180060000007. [PubMed:30020314 ]
- Kumar P, Dubey KK: Implication of mutagenesis and precursor supplementation towards the enhancement of lipstatin (an antiobesity agent) biosynthesis through submerged fermentation using Streptomyces toxytricini. 3 Biotech. 2018 Jan;8(1):29. doi: 10.1007/s13205-017-1049-2. Epub 2017 Dec 26. [PubMed:29291142 ]
- Xiao J, Wang G, Liu H, Dai X: Application of composted lipstatin fermentation residue as organic fertilizer: Temporal changes in soil characteristics and bacterial community. Chemosphere. 2022 Nov;306:135637. doi: 10.1016/j.chemosphere.2022.135637. Epub 2022 Jul 7. [PubMed:35810867 ]
- LOTUS database [Link]
|
|---|